Researchers at Ben-Gurion University of the Negev (BGU) have identified how two different classes of medication-the GLP-1 receptor agonist semaglutide and the anti-inflammatory drug colchicine-act on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results